These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 10282698)

  • 21. NHS cervical screening programme to introduce liquid based cytology.
    Mayor S
    BMJ; 2003 Oct; 327(7421):948. PubMed ID: 14576231
    [No Abstract]   [Full Text] [Related]  

  • 22. Costs and effectiveness of alternative strategies for cervical cancer screening in military beneficiaries.
    Maxwell GL; Carlson JW; Ochoa M; Krivak T; Rose GS; Myers ER
    Obstet Gynecol; 2002 Oct; 100(4):740-8. PubMed ID: 12383543
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ages and frequencies for cervical cancer screening.
    Knox EG
    Br J Cancer; 1976 Oct; 34(4):444-52. PubMed ID: 823954
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk targetting: an approach to cost-containment.
    Charny MC; Farrow SC
    Health Policy; 1986; 6(4):363-72. PubMed ID: 10311785
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Breast cancer screening; cost-effective in practice?
    De Koning HJ
    Eur J Radiol; 2000 Jan; 33(1):32-7. PubMed ID: 10674787
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost-effectiveness analysis for Pap smear screening and human papillomavirus DNA testing and vaccination.
    Chen MK; Hung HF; Duffy S; Yen AM; Chen HH
    J Eval Clin Pract; 2011 Dec; 17(6):1050-8. PubMed ID: 21679279
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Five-year routine cervical cancer screening rates and intervals in a US health plan.
    Schabert VF; Ye X; Insinga RP; Singhal PK; Riedel AA
    Curr Med Res Opin; 2008 Sep; 24(9):2429-35. PubMed ID: 18662493
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The cost-effectiveness of population Helicobacter pylori screening and treatment: a Markov model using economic data from a randomized controlled trial.
    Mason J; Axon AT; Forman D; Duffett S; Drummond M; Crocombe W; Feltbower R; Mason S; Brown J; Moayyedi P;
    Aliment Pharmacol Ther; 2002 Mar; 16(3):559-68. PubMed ID: 11876711
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Costs of detection and treatment of cervical cancer, cervical dysplasia and genital warts in the UK.
    Brown RE; Breugelmans JG; Theodoratou D; Bénard S
    Curr Med Res Opin; 2006 Apr; 22(4):663-70. PubMed ID: 16684427
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is it cost effective to introduce screening programmes for colorectal cancer? Illustrating the principles of optimal resource allocation.
    Gyrd-Hansen D
    Health Policy; 1997 Sep; 41(3):189-99. PubMed ID: 10170088
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The health and economic impact of cervical cancer screening and human papillomavirus vaccination in kidney transplant recipients.
    Wong G; Howard K; Webster A; Chapman JR; Craig JC
    Transplantation; 2009 Apr; 87(7):1078-91. PubMed ID: 19352131
    [TBL] [Abstract][Full Text] [Related]  

  • 32. De novo establishment and cost-effectiveness of Papanicolaou cytology screening services in the Socialist Republic of Vietnam.
    Suba EJ; Nguyen CH; Nguyen BD; Raab SS;
    Cancer; 2001 Mar; 91(5):928-39. PubMed ID: 11251944
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Health economic analysis of human papillomavirus vaccines in women of Chile: perspective of the health care payer using a Markov model.
    Gomez JA; Lepetic A; Demarteau N
    BMC Public Health; 2014 Nov; 14():1222. PubMed ID: 25424716
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Costs and cost effectiveness of cardiovascular screening and intervention: the British family heart study.
    Wonderling D; McDermott C; Buxton M; Kinmonth AL; Pyke S; Thompson S; Wood D
    BMJ; 1996 May; 312(7041):1269-73. PubMed ID: 8634617
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis B vaccination: the cost effectiveness of alternative strategies in England and Wales.
    Mangtani P; Hall AJ; Normand CE
    J Epidemiol Community Health; 1995 Jun; 49(3):238-44. PubMed ID: 7629457
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Moving towards an organized cervical cancer screening: costs and impact.
    Diaz M; Moriña D; Rodríguez-Salés V; Ibáñez R; Espinás JA; de Sanjosé S
    Eur J Public Health; 2018 Dec; 28(6):1132-1138. PubMed ID: 29684144
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Costs of population cervical cancer screening program in Poland between 2007-2009].
    Spaczyński M; Karowicz-Bilinska A; Kedzia W; Molińska-Glura M; Seroczyński P; Januszek-Michalecka L; Rokita W; Nowak-Markwitz E
    Ginekol Pol; 2010 Oct; 81(10):750-6. PubMed ID: 21117303
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A review of cervical cancer and cervical screening: implications for nursing practice.
    Ibbotson T; Wyke S
    J Adv Nurs; 1995 Oct; 22(4):745-52. PubMed ID: 8708195
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost-effectiveness analysis of different types of human papillomavirus vaccination combined with a cervical cancer screening program in mainland China.
    Mo X; Gai Tobe R; Wang L; Liu X; Wu B; Luo H; Nagata C; Mori R; Nakayama T
    BMC Infect Dis; 2017 Jul; 17(1):502. PubMed ID: 28720082
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cervical screening in general practice: call and recall.
    Ridsdale LL
    J R Coll Gen Pract; 1987 Jun; 37(299):257-9. PubMed ID: 3129556
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.